JPRN-UMIN000008578招募中未知
Efficacy and safety of abatacept in RA patients in daily clinical practice: An retrospective observational study Orencia as Biological Intensive Treatment for RA - ORBIT study
niversity of Occupational and Environmental Health, Japan0 个研究点目标入组 100 人开始时间: 2012年8月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 15years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who are inadequate by investigator's decision.
研究者
相似试验
已完成
不适用
Efficacy and safety of abatacept in RA patients in daily clinical practice: An retrospective observational studyRheumatoid ArthritisJPRN-UMIN000008285niversity of Occupational and Environmental Health, Japan50
进行中（未招募）
1 期
Safety of abatacept in Rheumatoid Arthritis associated Interstitial Lung DiseaseRheumatoid-associated Interstitial Lung Disease (RA-ILD)MedDRA version: 20.0Level: PTClassification code 10022611Term: Interstitial lung diseaseSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 20.0Level: LLTClassification code 10003268Term: Arthritis rheumatoidSystem Organ Class: 100000004859EUCTR2016-002569-68-GBCambridge University Hospitals NHS Foundation Trust30
已完成
2 期
Safety and efficacy of Abatacept in patients with treatment-resistant sarcoidosisD86.0Sarcoidosis of lungDRKS00011660niversitätsklinikum Freiburg30
进行中（未招募）
1 期
Safety and efficacy of Abatacept in patients with treatment-resistant sarcoidosisEUCTR2016-003360-39-DEniversitätsklinikum Freiburg30
招募中
不适用
Abatacept-based approach to cure of RARheumatoid ArthritisJPRN-UMIN000008756niversity of Occupational and Environmental Health, Japan40